Log in
Enquire now
‌

US Patent 11306324 AAV delivery of nucleobase editors

Patent 11306324 was granted and assigned to President and Fellows of Harvard College on April, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

TimelineTable: Further ResourcesReferences
Is a
Patent
Patent
1

Patent attributes

Patent Applicant
‌
President and Fellows of Harvard College
1
Current Assignee
‌
President and Fellows of Harvard College
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
113063241
Patent Inventor Names
Jonathan Ma Levy1
David R. Liu1
Wei Hsi Yeh1
Date of Patent
April 19, 2022
1
Patent Application Number
157840331
Date Filed
October 13, 2017
1
Patent Citations
‌
US Patent 10189831 Non-nucleoside reverse transcriptase inhibitors
‌
US Patent 10059940 Chemically ligated RNAs for CRISPR/Cas9-lgRNA complexes as antiviral therapeutic agents
‌
US Patent 10077453 CAS9 proteins including ligand-dependent inteins
‌
US Patent 10113163 Adenosine nucleobase editors and uses thereof
‌
US Patent 10150955 Stabilized reverse transcriptase fusion proteins
‌
US Patent 10167457 Nucleobase editors and uses thereof
1
‌
US Patent 10179911 Negative selection and stringency modulation in continuous evolution systems
‌
US Patent 10202658 Methods for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors
...
Patent Citations Received
‌
US Patent 11932884 High efficiency base editors comprising Gam
31
‌
US Patent 12006520 Evaluation and improvement of nuclease cleavage specificity
32
Loading...
33
‌
US Patent 12084663 Incorporation of unnatural amino acids into proteins using base editing
34
‌
US Patent 11661590 Programmable CAS9-recombinase fusion proteins and uses thereof
35
‌
US Patent 11578343 CAS9 proteins including ligand-dependent inteins
36
‌
US Patent 11643652 Methods and compositions for prime editing nucleotide sequences
37
‌
US Patent 11912985 Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
38
...
Patent Primary Examiner
‌
Catherine S Hibbert
1
CPC Code
‌
C12N 2750/14143
1
‌
C12N 15/62
1
‌
C12N 2830/36
1
‌
C12N 2830/48
1
‌
C12Y 305/04001
1
‌
C12Y 305/04004
1
‌
A61K 48/00
1
‌
C07K 2319/09
1
...

Provided herein are methods of delivering “split” Cas9 protein or nucleobase editors into a cell, e.g., via a recombinant adeno-associated virus (rAAV), to form a complete and functional Cas9 protein or nucleobase editor. The Cas9 protein or the nucleobase editor is split into two sections, each fused with one part of an intein system (e.g., intein-N and intein-C encoded by dnaEn and dnaEc, respectively). Upon co-expression, the two sections of the Cas9 protein or nucleobase editor are ligated together via intein-mediated protein splicing. Recombinant AAV vectors and particles for the delivery of the split Cas9 protein or nucleobase editor, and methods of using such AAV vectors and particles are also provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11306324 AAV delivery of nucleobase editors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.